Genomma Lab: third-quarter net sales up 1.3% and net profit up 18.6%
Genomma Lab Internacional reported that its net sales for the third quarter of 2026 rose 1.3%, with an EBITDA margin of 21.0% and net profit growth of 18.6%. Sales in Latin America increased 12.2%, while Mexico returned to positive sell-out. The information comes from the company's original press release, distributed by PR Newswire.
In 25 seconds
- Third-quarter 2026 net sales grew 1.3%
- Net profit rose 18.6% and the EBITDA margin stood at 21.0%
- Latin America sales increased 12.2% and Mexico returned to positive sell-out
IASummary generated by artificial intelligence from a story by TradingView. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.